Related Experiment Videos
Diabetic dyslipidaemia and coronary heart disease: new perspectives
1Department of Diabetes and Endocrinology, University Hospital of Wales, Health Park, Cardiff, UK.
Insights
Diabetic dyslipidaemia and oxidative stress contribute to endothelial dysfunction, a key factor in atherosclerotic macrovascular disease in type 2 diabetes. Addressing these may reduce vascular disease risk.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Endocrinology
Background:
- Atherosclerotic macrovascular disease is a major cause of death in type 2 diabetes.
- Endothelial dysfunction is an early, reversible event in atherosclerosis pathogenesis.
- Type 2 diabetes is associated with lipid abnormalities and oxidative stress.
Purpose of the Study:
- To hypothesize that endothelial dysfunction in type 2 diabetes stems from diabetic dyslipidaemia and oxidative stress.
- To explore the impact of post-prandial lipaemia and oxidative stress on nitric oxide action.
- To identify potential therapeutic strategies for reducing vascular risk in type 2 diabetes.
Main Methods:
- Review of in-vitro and human studies.
- Analysis of lipid and lipoprotein metabolism in type 2 diabetes.
- Investigation of oxidative stress markers and endothelial function.
Main Results:
- Type 2 diabetes exhibits hypertriglyceridaemia, low HDL, and post-prandial lipaemia.
- Enhanced oxidative stress is present in type 2 diabetes.
- A link between oxidative stress, post-prandial lipaemia, and endothelial dysfunction is suggested.
Conclusions:
- Endothelial dysfunction in type 2 diabetes is hypothesized to result from dyslipidaemia and oxidative stress.
- Therapeutic interventions targeting these mechanisms may mitigate vascular disease risk.
- Further research into nitric oxide pathways is warranted.
Abstract:
Atherosclerotic macrovascular disease is the leading cause of both morbidity and mortality in non-insulin dependent diabetes mellitus. Endothelial dysfunction is a key, early and potentially reversible event in pathogenesis of atherosclerosis. Its occurrence in non-insulin dependent diabetes mellitus is well supported by both in-vitro and in-vivo studies. Non-insulin dependent diabetes mellitus results in diverse abnormalities of lipid and lipoprotein metabolism, in particular hypertriglyceridaemia, low levels of high density lipoprotein and abnormalities of post-prandial lipaemia. A variety of studies demonstrate the presence of enhanced oxidative stress in non-insulin dependent diabetes mellitus, with recent data implying an association between oxidative stress, post-prandial lipaemia and endothelial dysfunction in non-diabetic subjects. In this article based on in-vitro and human studies, we develop the hypothesis that endothelial dysfunction in non-insulin dependent diabetes mellitus is the consequence of the diabetic dyslipidaemia, in particular post-prandial lipaemia, and of oxidative stress on the action of nitric oxide. The practical applications of this theory provide potential therapeutic options which may reduce the risk of vascular disease in non-insulin dependent diabetes mellitus.